Conditions: Actinic Keratosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 220
Healthy volunteers: no

Brief summary:
To identify the Maximum Tolerated Dose levels of LEO 43204 after once daily treatment for two consecutive days and to evaluate efficacy of LEO 43204 in two doses after once daily treatment for two consecutive days compared to vehicle

Detailed description:

Arms:
arm 1: Open-label, dose escalation, 2 days treatment arm 2: X dose for 2 days treatment arm 3: Y dose for 2 days treatment arm 4: Placebo for 2 days treatment

Interventions: intervention 1: LEO 43204 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: